Young Indians Face Hidden Epidemic: Diabetes & Fatty Liver Strike Early

• India faces a "hidden epidemic" of diabetes and fatty liver, affecting young, non-obese individuals earlier than ever, despite lower average BMI than Western countries.
• A unique South Asian metabolic profile, characterized by higher visceral fat at lower body weights, combined with poor lifestyle choices, drives this early onset.
• Conditions like insulin resistance and fatty liver are often asymptomatic, making early metabolic testing and comprehensive biomarker screening crucial for timely intervention.
• WHO guidelines emphasize careful patient selection, medical supervision, and long-term monitoring for GLP-1 drugs, ensuring they target overall metabolic health, not just weight loss.
• Advanced diagnostic tools, including comprehensive biomarker panels and AI integration, are vital for early risk identification, personalized prevention, and predicting disease years in advance.

Why It Matters: Early detection, comprehensive testing, and lifestyle changes are crucial to combat India's rising metabolic health crisis.